John L Stebbins Selected Research

Biomarkers (Surrogate Marker)

1/2020

Salivary total Immunoglobulin G as a surrogate marker of oral immune activity in salivary bioscience research.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John L Stebbins Research Topics

Disease

18	Neoplasms (Cancer) 03/2016 - 08/2007
6	Prostatic Neoplasms (Prostate Cancer) 07/2014 - 05/2010
4	Melanoma (Melanoma, Malignant) 07/2015 - 12/2009
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2010 - 07/2009
3	Leukemia 11/2010 - 07/2009
2	Inflammation (Inflammations) 01/2020 - 01/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016 - 07/2015
2	Lymphoma (Lymphomas) 01/2011 - 04/2009
1	Drug-Related Side Effects and Adverse Reactions 03/2016
1	Neoplasm Metastasis (Metastasis) 07/2015
1	Kidney Neoplasms (Kidney Cancer) 01/2013
1	Human Influenza (Influenza) 12/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2011
1	Alzheimer Disease (Alzheimer's Disease) 10/2011
1	Huntington Disease (Huntington's Disease) 10/2011
1	Lung Neoplasms (Lung Cancer) 01/2011
1	Hypoxia (Hypoxemia) 12/2009
1	Carcinogenesis 12/2009
1	Type 2 Diabetes Mellitus (MODY) 10/2008
1	Insulin Resistance 10/2008
1	Decompression Sickness (Bends) 12/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2011 - 08/2007
4	EphA2 ReceptorIBA 03/2016 - 03/2012
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2015 - 03/2012
4	Peptides (Polypeptides)IBA 07/2014 - 11/2008
4	apogossypolIBA 05/2011 - 04/2009
3	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 05/2010
3	1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamideIBA 11/2012 - 05/2010
2	CytokinesIBA 01/2020 - 05/2011
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 08/2013 - 12/2009
1	Immunoglobulin G (IgG)IBA 01/2020
1	Transferrin (beta 2 Transferrin)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	AdiponectinIBA 01/2017
1	Gemcitabine FDA Link 03/2016
1	NucleosidesIBA 03/2016
1	LigandsIBA 07/2015
1	Oseltamivir (Tamiflu)FDA Link 12/2012
1	LuciferasesIBA 12/2012
1	GossypolIBA 11/2012
1	Matrix Metalloproteinases (MMPs)IBA 05/2012
1	HemopexinIBA 05/2012
1	CollagenIBA 05/2012
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 05/2012
1	Glutamic Acid (Glutamate)FDA Link 10/2011
1	3- (3- (1H- benzo(d)imidazol- 2- yl)acryloyl)- 6- chloro- 4- phenylquinolin- 2(1H)- oneIBA 08/2011
1	Interleukin-10 (Interleukin 10)IBA 05/2011
1	ABT-737IBA 05/2011
1	InterleukinsIBA 05/2011
1	BI97D6IBA 01/2011
1	apogossypoloneIBA 11/2010
1	UbiquitinIBA 12/2009
1	Ligases (Synthetase)IBA 12/2009
1	Mitogen-Activated Protein KinasesIBA 12/2009
1	Vitamin K 3 (Menadione)FDA Link 12/2009
1	NF-kappa B (NF-kB)IBA 12/2009
1	4- (2,3- dihydro- 1,4- benzodioxin- 6- yl)- 2,4- dihydro- 5- ((5- nitro- 2- thiazolyl)thio)- 3H- 1,2,4- triazol- 3- oneIBA 10/2008
1	Proline (L-Proline)FDA Link 12/2007
1	Staphylococcal Protein A (Protein A)IBA 08/2007

Therapy/Procedure

10	Therapeutics 03/2016 - 04/2009
3	Drug Therapy (Chemotherapy) 03/2016 - 08/2007
1	Injections 05/2012